Quest Diagnostics Inc Cash and Cash Equivalents, Period Increase (Decrease)
Quest Diagnostics Inc (DGX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$222.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-23
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$213.00M.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $36.00M, a 70.73% decline year-over-year.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$53.00M, a 134.19% decline year-over-year.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $8.00M.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$222.00M, a 198.23% decline from fiscal 2016.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was $226.00M.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$59.00M, a 1280.00% decline from fiscal 2014.
- Quest Diagnostics Inc cash and cash equivalents, period increase (decrease) for fiscal 2014 was $5.00M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$213.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$177.00M derived: sum of 2 quarters · filed 2018-02-23 | -$230.00M derived: sum of 3 quarters · filed 2018-02-23 | -$222.00M 10-K · filed 2018-02-23 | ||||
| 2017-09-30 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | -$17.00M derived: sum of 2 quarters · filed 2017-10-19 | -$9.00M 10-Q · filed 2017-10-19 | -$56.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2017-06-30 | -$53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$45.00M 10-Q · filed 2017-07-25 | -$92.00M derived: sum of 3 quarters · filed 2018-02-23 | $31.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2017-03-31 | $8.00M 10-Q · filed 2017-04-21 | -$39.00M derived: sum of 2 quarters · filed 2018-02-23 | $84.00M derived: sum of 3 quarters · filed 2018-02-23 | $239.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-12-31 | -$47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $76.00M derived: sum of 2 quarters · filed 2018-02-23 | $231.00M derived: sum of 3 quarters · filed 2018-02-23 | $226.00M 10-K · filed 2018-02-23 | ||||
| 2016-09-30 | $123.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $278.00M derived: sum of 2 quarters · filed 2017-10-19 | $273.00M 10-Q · filed 2017-10-19 | $283.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $155.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $150.00M 10-Q · filed 2017-07-25 | $160.00M derived: sum of 3 quarters · filed 2018-02-23 | $133.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | -$5.00M 10-Q · filed 2017-04-21 | $5.00M derived: sum of 2 quarters · filed 2018-02-23 | -$22.00M derived: sum of 3 quarters · filed 2018-02-23 | -$846.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$17.00M derived: sum of 2 quarters · filed 2018-02-23 | -$841.00M derived: sum of 3 quarters · filed 2018-02-23 | -$59.00M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | -$27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | -$851.00M derived: sum of 2 quarters · filed 2016-10-21 | -$69.00M 10-Q · filed 2016-10-21 | -$47.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | -$824.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-25 | -$42.00M 10-Q · filed 2016-07-25 | -$20.00M derived: sum of 3 quarters · filed 2017-02-22 | $6.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $782.00M 10-Q · filed 2016-04-27 | $804.00M derived: sum of 2 quarters · filed 2017-02-22 | $830.00M derived: sum of 3 quarters · filed 2017-02-22 | $830.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $48.00M derived: sum of 2 quarters · filed 2017-02-22 | $48.00M derived: sum of 3 quarters · filed 2017-02-22 | $5.00M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $26.00M derived: sum of 2 quarters · filed 2015-10-29 | -$17.00M 10-Q · filed 2015-10-29 | $12.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$43.00M 10-Q · filed 2015-07-30 | -$14.00M derived: sum of 3 quarters · filed 2016-02-26 | -$4.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$43.00M 10-Q · filed 2015-04-30 | -$14.00M derived: sum of 2 quarters · filed 2016-02-26 | -$4.00M derived: sum of 3 quarters · filed 2016-02-26 | -$16.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $39.00M derived: sum of 2 quarters · filed 2016-02-26 | $27.00M derived: sum of 3 quarters · filed 2016-02-26 | -$126.00M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$2.00M derived: sum of 2 quarters · filed 2014-10-30 | -$155.00M 10-Q · filed 2014-10-30 | -$154.54M 10-Q · filed 2013-10-24 | -$33.88M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$165.00M 10-Q · filed 2014-07-31 | -$164.48M 10-Q · filed 2013-07-25 | -$43.88M derived: sum of 3 quarters · filed 2015-02-24 | -$25.86M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | -$153.00M 10-Q · filed 2014-05-01 | -$152.59M 10-Q · filed 2013-04-24 | -$31.88M derived: sum of 2 quarters · filed 2015-02-24 | -$13.86M derived: sum of 3 quarters · filed 2015-02-24 | $14.45M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $121.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $139.14M derived: sum of 2 quarters · filed 2015-02-24 | $167.45M derived: sum of 3 quarters · filed 2015-02-24 | $148.00M 10-K · filed 2015-02-24 | $147.93M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $18.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $46.33M derived: sum of 2 quarters · filed 2013-10-24 | $26.88M 10-Q · filed 2013-10-24 | $81.36M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-06-30 | $28.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $8.86M 10-Q · filed 2013-07-25 | $63.33M derived: sum of 3 quarters · filed 2014-02-18 | -$10.06M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-03-31 | -$19.45M 10-Q · filed 2013-04-24 | $35.03M derived: sum of 2 quarters · filed 2014-02-18 | -$38.36M derived: sum of 3 quarters · filed 2014-02-18 | -$848.39M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2011-12-31 | $54.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | -$18.92M derived: sum of 2 quarters · filed 2014-02-18 | -$828.94M derived: sum of 3 quarters · filed 2014-02-18 | -$284.00M 10-K · filed 2014-02-18 | -$284.42M 10-K · filed 2012-02-16 | |||
| 2011-09-30 | -$73.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$883.42M derived: sum of 2 quarters · filed 2012-10-24 | -$338.48M 10-Q · filed 2012-10-24 | -$258.44M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | -$810.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$265.08M 10-Q · filed 2012-07-26 | -$185.04M derived: sum of 3 quarters · filed 2013-02-27 | -$263.67M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $544.94M 10-Q · filed 2012-04-27 | $624.98M derived: sum of 2 quarters · filed 2013-02-27 | $546.35M derived: sum of 3 quarters · filed 2013-02-27 | $531.00M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $80.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.41M derived: sum of 2 quarters · filed 2013-02-27 | -$13.94M derived: sum of 3 quarters · filed 2013-02-27 | -$84.95M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | -$78.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$93.98M derived: sum of 2 quarters · filed 2011-11-03 | -$165.00M 10-Q · filed 2011-11-03 | $122.23M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-06-30 | -$15.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | -$86.37M 10-Q · filed 2011-07-27 | $200.85M derived: sum of 3 quarters · filed 2012-02-16 | $328.59M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-03-31 | -$71.02M 10-Q · filed 2011-05-10 | $216.21M derived: sum of 2 quarters · filed 2012-02-16 | $343.94M derived: sum of 3 quarters · filed 2012-02-16 | $259.02M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2009-12-31 | $287.22M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $414.96M derived: sum of 2 quarters · filed 2012-02-16 | $330.04M derived: sum of 3 quarters · filed 2012-02-16 | $280.31M 10-K · filed 2012-02-16 | ||||
| 2009-09-30 | $127.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $42.81M derived: sum of 2 quarters · filed 2010-10-26 | -$6.91M 10-Q · filed 2010-10-26 | -$39.65M derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-06-30 | -$84.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-27 | -$134.65M 10-Q · filed 2010-07-27 | -$167.38M derived: sum of 3 quarters · filed 2011-02-16 | -$24.10M derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-03-31 | -$49.73M 10-Q · filed 2010-04-26 | -$82.46M derived: sum of 2 quarters · filed 2011-02-16 | $60.82M derived: sum of 3 quarters · filed 2011-02-16 | |||||
| 2008-12-31 | -$32.73M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-16 | $110.55M derived: sum of 2 quarters · filed 2011-02-16 | $86.35M 10-K · filed 2011-02-16 | |||||
| 2008-09-30 | $143.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-27 | $119.08M 10-Q · filed 2009-10-27 | ||||||
| 2008-06-30 | -$24.20M 10-Q · filed 2009-07-28 | |||||||
| 2007-12-31 | $17.95M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |